Article - Limited access to UNIGE
Other version: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=toc&SEARCH=00004836-201103000-00000.kc&LINKTYPE=asBody&LINK...
Octreotide bolus injection and azygos blood flow in patients with cirrhosis: is the effect really predictable?
|Published in||Journal of Clinical Gastroenterology. 2010, vol. 44, no. 9, p. e206-209|
|Abstract||BACKGROUND: Octreotide (OCT) improves the management of variceal bleeding, but the pattern of administration is not clearly defined. Available data show a transient decrease in portal pressure and azygos blood flow (AzBF) after OCT bolus injection with desensitization at readministration. AIM: To explore the sustained hemodynamic effects of OCT and changes associated with readministration at 60 minutes on AzBF in patients with portal hypertension. PATIENTS AND METHODS: AzBF was measured invasively (thermodilution technique) in 12 patients at baseline and at 10 minutes intervals after OCT 50-mug IV bolus for a total of 60 minutes. Readministration of OCT was followed by AzBF measurement for another 15 minutes. Patients [age 51.4 y (30 to 69)] had cirrhosis (alcoholic in 9 patients; Pugh's score 8.8+/-0.3), portal hypertension (HVPG 19+/-1 mm Hg), and elevated AzBF (658+/-138 mL/min). RESULTS: The bolus of OCT was followed at 10 minutes by a 34% decline in AzBF as compared with baseline value. This AzBF reduction was sustained over the 60-minute study period (-36%+/-1.4%) with the values that remained decreased as compared with baseline (P<0.01). Mean arterial pressure remained stable. At 60 minutes, the repeat OCT bolus induced a further significant (P<0.01) decline in AzBF, although the response was blunted (-18%+/-1.2%). CONCLUSION: The AzBF showed a sustained decrease of value after a bolus injection of 50-mug OCT. A further hemodynamic response is detectable at OCT readministration after 60 minutes. The pattern of hemodynamic response to OCT may not be uniform among cirrhotics.|
|Keywords||Adult — Aged — Azygos Vein/drug effects — Female — Gastrointestinal Agents/administration & dosage/pharmacology — Hemodynamics — Humans — Hypertension, Portal/ drug therapy/physiopathology — Liver Cirrhosis/ complications/drug therapy — Liver Cirrhosis, Alcoholic/complications — Male — Middle Aged — Octreotide/administration & dosage/ pharmacology — Portal Pressure/ drug effects — Thermodilution — Time Factors|
|Research group||Hépatologie chirurgicale (327)|
|SPAHR, Laurent François Joséph et al. Octreotide bolus injection and azygos blood flow in patients with cirrhosis: is the effect really predictable?. In: Journal of Clinical Gastroenterology, 2010, vol. 44, n° 9, p. e206-209. doi: 10.1097/MCG.0b013e3181c4f111 https://archive-ouverte.unige.ch/unige:20710|